A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Argenx Se stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,412 shares of ARGX stock, worth $2.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,412
Previous 3,805 10.33%
Holding current value
$2.02 Million
Previous $1.64 Million 13.08%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$434.22 - $551.9 $170,648 - $216,896
-393 Reduced 10.33%
3,412 $1.85 Million
Q2 2024

Jul 30, 2024

BUY
$356.01 - $451.55 $1.35 Million - $1.72 Million
3,805 New
3,805 $1.64 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $32.7B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.